Article info

Download PDFPDF

4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study
Free

Authors

Citation

Calvo-Aranda E, Canamares-Orbis I, Novella-Navarro M, et al
4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study

Publication history

  • First published March 14, 2021.
Online issue publication 
March 14, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.